Log In
BCIQ
Print this Print this
 

CMC-001

  Manage Alerts
Collapse Summary General Information
Company CMC Contrast AB
DescriptionOral manganese-based contrast agent.
Molecular Target Not available
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase II
Standard IndicationCancer, Diagnostic
Indication DetailsDetect liver tumors; Detection and localization of focal liver lesions in patients where gadolinium-based contrast agents are contraindicated or cannot be administered
Regulatory Designation U.S. - Orphan Drug (Detection and localization of focal liver lesions in patients where gadolinium-based contrast agents are contraindicated or cannot be administered)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today